Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19* 2 loss-of-function allele or proton pump inhibitor coadministration: a …
Objectives: The aim of this study was to assess the association between the loss-of-function
cytochrome P450 2C19 (CYP2C19)* 2 variant (10 studies, 11,959 patients) or the use of …
cytochrome P450 2C19 (CYP2C19)* 2 variant (10 studies, 11,959 patients) or the use of …
Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19* 2 loss-of-function allele or proton pump inhibitor coadministration: a …
JS Hulot, JP Collet, J Silvain, A Pena… - Journal of the …, 2010 - europepmc.org
Objectives The aim of this study was to assess the association between the loss-of-function
cytochrome P450 2C19 (CYP2C19)* 2 variant (10 studies, 11,959 patients) or the use of …
cytochrome P450 2C19 (CYP2C19)* 2 variant (10 studies, 11,959 patients) or the use of …
Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19* 2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration
JS Hulot, JP Collet, J Silvain, A Pena… - Journal of the American …, 2010 - infona.pl
The aim of this study was to assess the association between the loss-of-function cytochrome
P450 2C19 (CYP2C19)* 2 variant (10 studies, 11,959 patients) or the use of proton pump …
P450 2C19 (CYP2C19)* 2 variant (10 studies, 11,959 patients) or the use of proton pump …
[引用][C] Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19* 2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration …
JS HULOT, JP COLLET, J SILVAIN… - Journal of the …, 2010 - pascal-francis.inist.fr
Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2
Loss-of-Function Allele or Proton Pump Inhibitor Coadministration: A Systematic Meta-Analysis …
Loss-of-Function Allele or Proton Pump Inhibitor Coadministration: A Systematic Meta-Analysis …
[PDF][PDF] Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19* 2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration
JS Hulot, JP Collet, J Silvain, A Pena… - Journal of the American …, 2010 - core.ac.uk
Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2
Loss-of-Function Allele or Proton Pump I Page 1 Antiplatelet Therapy Cardiovascular Risk …
Loss-of-Function Allele or Proton Pump I Page 1 Antiplatelet Therapy Cardiovascular Risk …
[引用][C] Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19* 2 loss-of-function allele or proton pump inhibitor coadministration: A …
H JS - J Am Coll Cardiol, 2010 - cir.nii.ac.jp
Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2
loss-of-function allele or proton pump inhibitor coadministration : A systematic meta-analysis …
loss-of-function allele or proton pump inhibitor coadministration : A systematic meta-analysis …
[PDF][PDF] Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19* 2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration
JS Hulot, JP Collet, J Silvain, A Pena… - Journal of the …, 2010 - academia.edu
Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2
Loss-of-Function Allele or Proton Pump I Page 1 Antiplatelet Therapy Cardiovascular Risk …
Loss-of-Function Allele or Proton Pump I Page 1 Antiplatelet Therapy Cardiovascular Risk …
Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19* 2 loss-of-function allele or proton pump inhibitor coadministration: a …
JS Hulot, JP Collet, J Silvain, A Pena… - Journal of the …, 2010 - pubmed.ncbi.nlm.nih.gov
Objectives The aim of this study was to assess the association between the loss-of-function
cytochrome P450 2C19 (CYP2C19)* 2 variant (10 studies, 11,959 patients) or the use of …
cytochrome P450 2C19 (CYP2C19)* 2 variant (10 studies, 11,959 patients) or the use of …
[HTML][HTML] Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19* 2 Loss-of-Function Allele or Proton Pump Inhibitor …
JS Hulot, JP Collet, J Silvain, A Pena… - Journal of the American …, 2010 - Elsevier
OBJECTIVES: The aim of this study was to assess the association between the loss-of-
function cytochrome P450 2C19 (CYP2C19)* 2 variant (10 studies, 11,959 patients) or the …
function cytochrome P450 2C19 (CYP2C19)* 2 variant (10 studies, 11,959 patients) or the …
[PDF][PDF] Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19* 2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration
JS Hulot, JP Collet, J Silvain, A Pena… - Journal of the …, 2010 - nnt.pharm.su.ac.th
Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2
Loss-of-Function Allele or Proton Pump I Page 1 Antiplatelet Therapy Cardiovascular Risk …
Loss-of-Function Allele or Proton Pump I Page 1 Antiplatelet Therapy Cardiovascular Risk …